Effects of Remote Ischaemic Preconditioning in Cemented Hip Arthroplasty.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-90
SponsorUniversity of Tartu

About this trial

Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.

Eligibility criteria

Qualifiers

age >65 years

undergoing total hip cemented hip arthroplasty

Disqualifiers

previously diagnosed peripheral artery disease on both upper limb

RIPC is contraindicated

Trial design

Treatments tested in this trial

  • Remote Ischemic Preconditioning
  • SHAM

Treatment groups

200 Participants
are divided into 2 treatment groups

Sponsors and collaborators